SARAH WALTKE: Open Payments
NPI 1659758134 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,392 in 47 payments from 22 companies in 2025. Trend: 2023 $132 · 2024 $0 · 2025 $1,392
Food & beverage: $1,069Education: $323
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $281 |
| Gilead Sciences, Inc. | 3 | $196 |
| Novartis Pharmaceuticals Corporation | 5 | $104 |
| Merck Sharp & Dohme LLC | 4 | $104 |
| E.R. Squibb & Sons, L.L.C. | 4 | $93 |
| Genentech USA, Inc. | 3 | $80 |
| BeOne Medicines USA, Inc. | 3 | $80 |
| Daiichi Sankyo Inc. | 1 | $70 |
| GlaxoSmithKline, LLC. | 2 | $49 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
Products named: Trodelvy, RYBREVANT, KEYTRUDA, ERLEADA, Enhertu, KISQALI, BRUKINSA, CARVYKTI.
Industry payments across MO — which companies pay providers there.
